Intimal hyperplasia leading to restenosis is the major process that limits the success of cardiovascular intervention. The emergence of vascular progenitor cells and, in particular, endothelial progenitor cells has led to great interest in their potential therapeutic value in preventing intimal hyperplasia. We review the mechanism of intimal hyperplasia and highlight the important attenuating role played by a functional endothelium. The role of endothelial progenitor cells in maintaining endothelial function is reviewed and we describe how reduced progenitor cell number and function and reduced endothelial function lead to an increased risk of intimal hyperplasia. We review other potential sources of endothelial cells, including monocytes, mesenchymal stem cells and tissue resident stem cells. Endothelial progenitor cells have been used in clinical trials to reduce the risk of restenosis with varied success. Progenitor cells have huge therapeutic potential to prevent intimal hyperplasia but a more detailed understanding of vascular progenitor cell biology is necessary before further clinical trials are commenced.
Aicher, A., Heeschen, C., Mildner-Rihm, C., Urbich, C., Ihling, C., Technau-Ihling, K. et al. (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med9: 1370-1376.
2.
Aoki, J., Serruys, P.W., van Beusekom, H., Ong, A.T., McFadden, E.P., Sianos, G. et al. (2005) Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy
3.
Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry . J Am Coll Cardiol45: 1574-1579.
4.
Asahara, T., Bauters, C., Pastore, C., Kearney, M., Rossow, S., Bunting, S. et al. (1995) Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation91: 2793-2801.
5.
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M. et al. (1999a) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res85: 221-228.
6.
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T. et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis . Science275: 964-967.
7.
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H. et al. (1999b) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J18: 3964-3972.
8.
Ascher, E., Gade, P., Hingorani, A., Mazzariol, F., Gunduz, Y., Fodera, M. et al. (2000) Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations. J Vasc Surg31: 84-92.
9.
Autiero, M., Luttun, A., Tjwa, M. and Carmeliet, P. ( 2003) Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders . J Thromb Haemost1: 1356-1370.
10.
Banerjee, S., Brilakis, E., Zhang, S., Roesle, M., Lindsey, J., Philips, B. et al. (2006) Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis189: 70-75.
11.
Barleon, B., Sozzani, S., Zhou, D., Weich, H.A., Mantovani, A. and Marme, D. ( 1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood87: 3336-3343.
12.
Bath, P.M., Hassall, D.G., Gladwin, A.M., Palmer, R.M. and Martin, J.F. ( 1991) Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb11: 254-260.
13.
Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S. et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell114: 763-776.
14.
Bonetti, P.O., Lerman, L.O. and Lerman, A. ( 2003) Endothelial dysfunction: a marker of atherosclerotic risk . Arterioscler Thromb Vasc Biol23: 168-175.
15.
Burger, P.E., Coetzee, S., McKeehan, W.L., Kan, M., Cook, P., Fan, Y. et al. (2002) Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood100: 3527-3535.
16.
Case, J., Mead, L.E., Bessler, W.K., Prater, D., White, H.A., Saadatzadeh, M.R. et al. (2007) Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol35: 1109-1118.
17.
Celermajer, D.S., Sorensen, K.E., Bull, C., Robinson, J. and Deanfield, J.E. ( 1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction . J Am Coll Cardiol24: 1468-1474.
18.
Chen, J.Z., Zhang, F.R., Tao, Q.M., Wang, X.X., Zhu, J.H. and Zhu, J.H. ( 2004) Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 107: 273-280.
19.
Cho, H.J., Kim, H.S., Lee, M.M., Kim, D.H., Yang, H.J., Hur, J. et al. (2003) Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation108: 2918-2925.
20.
Cipollone, F., Marini, M., Fazia, M., Pini, B., Iezzi, A., Reale, M. et al. (2001) Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol21: 327-334.
21.
Clowes, A.W. and Karnowsky, M.J. ( 1977) Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature265: 625-626.
22.
Co, M., Tay, E., Lee, C.H., Poh, K.K., Low, A., Lim, J. et al. (2008) Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. Am Heart J155: 128-132.
23.
Corson, J.D., Leather, R.P., Balko, A., Naraynsingh, V., Karmody, A.M. and Shah, D.M. ( 1985) Relationship between vasa vasorum and blood flow to vein bypass endothelial morphology. Arch Surg120: 386-388.
24.
Costa, M.A. and Simon, D.I. ( 2005) Molecular basis of restenosis and drug-eluting stents . Circulation111: 2257-2273.
25.
De, F.E., Porcelli, D., Torella, A.R., Straino, S., Iachininoto, M.G., Orlandi, A. et al. (2004) SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood104: 3472-3482.
26.
DeRuiter, M.C., Poelmann, R.E., VanMunsteren, J.C., Mironov, V., Markwald, R.R. and Gittenbergerde Groot, A.C. ( 1997) Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res80: 444-451.
27.
Dimmeler, S. and Leri, A. ( 2008) Aging and disease as modifiers of efficacy of cell therapy . Circ Res102: 1319-1330.
28.
Duckers, H.J., Silber, S., de Winter, R., den Heijer, P., Rensing, B., Rau, M. et al. (2007a) Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention3: 67-75.
29.
Duckers, H.J., Soullie, T., den Heijer, P., Rensing, B., de Winter, R.J., Rau, M. et al. (2007b) Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention3: 350-358.
30.
Farb, A., Kolodgie, F.D., Hwang, J.Y., Burke, A.P., Tefera, K., Weber, D.K. et al. (2004) Extracellular matrix changes in stented human coronary arteries. Circulation110: 940-947.
31.
Fernandez, P.B., Lucibello, F.C., Gehling, U.M., Lindemann, K., Weidner, N., Zuzarte, M.L. et al. (2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation65: 287-300.
32.
Forrester, J.S., Fishbein, M., Helfant, R. and Fagin, J. ( 1991) A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol17: 758-769.
33.
Frericks, H., Kievit, J., van Baalen, J.M. and van Bockel, J.H. ( 1998) Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature. Stroke29: 244-250.
34.
Fujiyama, S., Amano, K., Uehira, K., Yoshida, M., Nishiwaki, Y., Nozawa, Y. et al. (2003) Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res93: 980-989.
35.
Furukawa, Y., Matsumori, A., Ohashi, N., Shioi, T., Ono, K., Harada, A. et al. (1999) Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res84: 306-314.
36.
George, J., Herz, I., Goldstein, E., Abashidze, S., Deutch, V., Finkelstein, A. et al. (2003) Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol23: e57-e60.
37.
George, J., Shmilovich, H., Deutsch, V., Miller, H., Keren, G. and Roth, A. ( 2006) Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng12: 331-335.
38.
Gill, M., Dias, S., Hattori, K., Rivera, M.L., Hicklin, D., Witte, L. et al. (2001) Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res88: 167-174.
39.
Goldman, S., Zadina, K., Moritz, T., Ovitt, T., Sethi, G., Copeland, J.G. et al. (2004) Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol44: 2149-2156.
40.
Gronthos, S., Franklin, D.M., Leddy, H.A., Robey, P.G., Storms, R.W. and Gimble, J.M. ( 2001) Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol189: 54-63.
41.
Groschel, K., Riecker, A., Schulz, J.B., Ernemann, U. and Kastrup, A. ( 2005) Systematic review of early recurrent stenosis after carotid angioplasty and stenting. Stroke36: 367-373.
42.
Hedman, M., Hartikainen, J., Syvanne, M., Stjernvall, J., Hedman, A., Kivela, A. et al. (2003) Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT) . Circulation107: 2677-2683.
43.
Heiss, C., Keymel, S., Niesler, U., Ziemann, J., Kelm, M. and Kalka, C. ( 2005) Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol45: 1441-1448.
44.
Hibbert, B., Chen, Y.X. and O’Brien, E.R. ( 2004) C-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions . Am J Physiol Heart Circ Physiol287: H518-H524.
45.
Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A. et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med348: 593-600.
46.
Hiltunen, M.O., Laitinen, M., Turunen, M.P., Jeltsch, M., Hartikainen, J., Rissanen, T.T. et al. (2000) Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation102: 2262-2268.
47.
Horvath, C., Welt, F.G., Nedelman, M., Rao, P. and Rogers, C. ( 2002) Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ Res90: 488-494.
48.
Hu, Y., Davison, F., Ludewig, B., Erdel, M., Mayr, M., Url, M. et al. (2002a) Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells . Circulation106: 1834-1839.
49.
Hu, Y., Davison, F., Zhang, Z. and Xu, Q. ( 2003) Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation108: 3122-3127.
50.
Hu, Y., Mayr, M., Metzler, B., Erdel, M., Davison, F. and Xu, Q. ( 2002b) Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res91: e13-e20.
51.
Hu, Y., Zhang, Z., Torsney, E., Afzal, A.R., Davison, F., Metzler, B. et al. (2004) Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest113: 1258-1265.
52.
Hur, J., Yoon, C.H., Kim, H.S., Choi, J.H., Kang, H.J., Hwang, K.K. et al. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol24: 288-293.
53.
Ingram, D.A., Mead, L.E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K. et al. (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood104: 2752-2760.
54.
Ishiwata, S., Tukada, T., Nakanishi, S., Nishiyama, S. and Seki, A. ( 1997) Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J133: 387-392.
55.
Ishizawa, K., Kubo, H., Yamada, M., Kobayashi, S., Suzuki, T., Mizuno, S. et al. (2004) Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun324: 276-280.
56.
Jackson, K.A., Majka, S.M., Wang, H., Pocius, J., Hartley, C.J., Majesky, M.W. et al. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest107: 1395-1402.
57.
Jackson, K.A., Mi, T. and Goodell, M.A. ( 1999) Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A96: 14482-14486.
58.
Jankowski, R.J., Deasy, B.M. and Huard, J. ( 2002) Muscle-derived stem cells. Gene Ther9: 642-647.
59.
Kang, H.J., Kim, H.S., Zhang, S.Y., Park, K.W., Cho, H.J., Koo, B.K. et al. (2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet363: 751-756.
60.
Kashiwakura, Y., Katoh, Y., Tamayose, K., Konishi, H., Takaya, N., Yuhara, S. et al. (2003) Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow. Circulation107: 2078-2081.
61.
Kearney, M., Pieczek, A., Haley, L., Losordo, D.W., Andres, V., Schainfeld, R. et al. (1997) Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation95: 1998-2002.
62.
Kennedy, J.H., Lever, M.J., Addis, B.J. and Paneth, M. ( 1989) Changes in vein interstitium following distension for aortocoronary bypass. J Cardiovasc Surg ( Torino) 30: 992-995.
63.
Khakoo, A.Y. and Finkel, T. ( 2005) Endothelial progenitor cells. Annu Rev Med56: 79-101.
64.
Kim, I., Moon, S.O., Kim, S.H., Kim, H.J., Koh, Y.S. and Koh, G.Y. ( 2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells . J Biol Chem276: 7614-7620.
65.
Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S. et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation109: 1543-1549.
66.
Kitta, Y., Nakamura, T., Kodama, Y., Takano, H., Umetani, K., Fujioka, D. et al. (2005) Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. J Am Coll Cardiol46: 648-655.
67.
Klomp, M., Beijk, M.A., Verouden, N.J., Tijssen, J.G. and de Winter, R.J.(2009) Design and rationale of the TRI-stent adjudication study (TRIAS) program . Am Heart J158: 527-532.
68.
Kondo, T., Hayashi, M., Takeshita, K., Numaguchi, Y., Kobayashi, K., Iino, S. et al. (2004) Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol24: 1442-1447.
69.
Kong, D., Melo, L.G., Gnecchi, M., Zhang, L., Mostoslavsky, G., Liew, C.C. et al. (2004a) Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation110: 2039-2046.
70.
Kong, D., Melo, L.G., Mangi, A.A., Zhang, L., Lopez-Ilasaca, M., Perrella, M.A. et al. (2004b) Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation109: 1769-1775.
71.
Kwon, H.M., Sangiorgi, G., Ritman, E.L., Lerman, A., McKenna, C., Virmani, R. et al. (1998) Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol32: 2072-2079.
72.
Landmesser, U., Hornig, B. and Drexler, H. ( 2004) Endothelial function: a critical determinant in atherosclerosis?Circulation109: 1127-1133.
73.
Lattimer, C.R. and Burnand, K.G. ( 1997) Recurrent carotid stenosis after carotid endarterectomy . Br J Surg84: 1206-1219.
74.
Laufs, U., Werner, N., Link, A., Endres, M., Wassmann, S., Jurgens, K. et al. (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation109: 220-226.
75.
Li, B., Sharpe, E.E., Maupin, A.B., Teleron, A.A., Pyle, A.L., Carmeliet, P. et al. (2006) VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization . FASEB J20: 1495-1497.
76.
Lindner, V., Olson, N.E., Clowes, A.W. and Reidy, M.A. ( 1992) Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J Clin Invest90: 2044-2049.
77.
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L. et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med7: 1194-1201.
78.
Mann, J.M., McIntosh, C.L. and Roberts, W.C. ( 1987) Spasm of saphenous veins used as conduits for aortocoronary bypass grafting. Am J Cardiol59: 1000-1002.
79.
Marek, J.M., Koehler, C., Aguirre, M.L., Westerband, A., Gentile, A.T., Mills, J.L. et al. (1998) The histologic characteristics of primary and restenotic carotid plaque. J Surg Res74: 27-33.
80.
Marumo, T., Schini-Kerth, V.B. and Busse, R. ( 1999) Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes48: 1131-1137.
81.
Matsuo, Y., Imanishi, T., Hayashi, Y., Tomobuchi, Y., Kubo, T., Hano, T. et al. (2006) The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting. Intern Med45: 581-587.
82.
McEver, R.P. and Cummings, R.D. ( 1997) Role of PSGL-1 binding to selectins in leukocyte recruitment . J Clin Invest100: S97-S103.
83.
Miglionico, M., Patti, G., D’Ambrosio, A. and Di, S.G. ( 2008) Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Catheter Cardiovasc Interv71: 600-604.
84.
Moore, M.A., Hattori, K., Heissig, B., Shieh, J.H., Dias, S., Crystal, R.G. et al. (2001) Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci938: 36-45.
85.
Muradin, G.S., Bosch, J.L., Stijnen, T. and Hunink, M.G. ( 2001) Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology221: 137-145.
86.
Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Uematsu, M. et al. (2004) Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol287: H2670-H2676.
87.
Noort, W.A., Kruisselbrink, A.B., in’t Anker, P.S., Kruger, M., van Bezooijen, R.L., de Paus, R.A. et al. (2002) Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol30: 870-878.
88.
O’Brien, E.R., Garvin, M.R., Dev, R., Stewart, D.K., Hinohara, T., Simpson, J.B. et al. (1994) Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol145: 883-894.
89.
Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F. et al. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A98: 10344-10349.
90.
Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Ehninger, G., Bornhauser, M. et al. (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells22: 377-384.
91.
Patti, G., Pasceri, V., Melfi, R., Goffredo, C., Chello, M., D’Ambrosio, A. et al. (2005) Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation111: 70-75.
92.
Peters, K.G., de Vries, C. and Williams, L.T.(1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A90: 8915-8919.
93.
Rehman, J., Li, J., Orschell, C.M. and March, K.L. ( 2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation107: 1164-1169.
94.
Reyes, M., Dudek, A., Jahagirdar, B., Koodie, L., Marker, P.H. and Verfaillie, C.M. ( 2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest109: 337-346.
95.
Roberts, N., Xiao, Q., Weir, G., Xu, Q. and Jahangiri, M. ( 2007) Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg83: 598-605.
96.
Rohde, E., Malischnik, C., Thaler, D., Maierhofer, T., Linkesch, W., Lanzer, G. et al. (2006) Blood monocytes mimic endothelial progenitor cells. Stem Cells24: 357-367.
97.
Roiron, C., Sanchez, P., Bouzamondo, A., Lechat, P. and Montalescot, G. ( 2006) Drug-eluting stents: a meta-analysis of randomised controlled trials. Heart92(5): 641-649.
98.
Roque, M., Kim, W.J., Gazdoin, M., Malik, A., Reis, E.D., Fallon, J.T. et al. (2002) CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol22: 554-559.
99.
Ross, R. ( 1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature362: 801-809.
100.
Rossi, M.L., Zavalloni, D., Gasparini, G.L., Mango, R., Belli, G. and Presbitero, P. ( 2009) The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent. Int J Cardiol Jan 8 [Epub ahead of print].
Ryan, J. and Cohen, D.J. ( 2006) Are drug-eluting stents cost-effective? It depends on whom you ask. Circulation114: 1736-1743.
103.
Saiura, A., Sata, M., Hirata, Y., Nagai, R. and Makuuchi, M. ( 2001) Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med7: 382-383.
104.
Sandri, M., Adams, V., Gielen, S., Linke, A., Lenk, K., Krankel, N. et al. (2005) Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation111: 3391-3399.
105.
Sata, M., Saiura, A., Kunisato, A., Tojo, A., Okada, S., Tokuhisa, T. et al. (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med8: 403-409.
106.
Schmidt-Lucke, C., Rossig, L., Fichtlscherer, S., Vasa, M., Britten, M., Kamper, U. et al. (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation111: 2981-2987.
107.
Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Honma, T., Katoh, A. et al. (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation103: 2776-2779.
108.
Shoji, M., Sata, M., Fukuda, D., Tanaka, K., Sato, T., Iso, Y. et al. (2004) Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling. Cardiovasc Pathol13: 306-312.
109.
Simper, D., Stalboerger, P.G., Panetta, C.J., Wang, S. and Caplice, N.M. ( 2002) Smooth muscle progenitor cells in human blood. Circulation106: 1199-1204.
110.
Smith, S.H. and Geer, J.C. ( 1983) Morphology of saphenous vein-coronary artery bypass grafts: Seven to 116 months after surgery. Arch Pathol Lab Med107: 13-18.
111.
Snow, A.D., Bolender, R.P., Wight, T.N. and Clowes, A.W. ( 1990) Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol137: 313-330.
112.
Strauss, B.H., Chisholm, R.J., Keeley, F.W., Gotlieb, A.I., Logan, R.A. and Armstrong, P.W. ( 1994) Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res75: 650-658.
113.
Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M. et al. (1999) Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization . Nat Med5: 434-438.
114.
Takamiya, M., Okigaki, M., Jin, D., Takai, S., Nozawa, Y., Adachi, Y. et al. (2006) Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/ Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol26: 751-757.
115.
Tang, Y.L., Zhao, Q., Zhang, Y.C., Cheng, L., Liu, M., Shi, J. et al. (2004) Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept117: 3-10.
116.
Tepper, O.M., Galiano, R.D., Capla, J.M., Kalka, C., Gagne, P.J., Jacobowitz, G.R. et al. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation106: 2781-2786.
Tuli, R., Seghatoleslami, M.R., Tuli, S., Wang, M.L., Hozack, W.J., Manner, P.A. et al. (2003) A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol23: 37-49.
119.
Urbich, C. and Dimmeler, S. ( 2004) Endothelial progenitor cells functional characterization . Trends Cardiovasc Med14: 318-322.
120.
Urbich, C., Heeschen, C., Aicher, A., Dernbach, E., Zeiher, A.M. and Dimmeler, S. ( 2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation108: 2511-2516.
121.
Valina, C., Pinkernell, K., Song, Y.H., Bai, X., Sadat, S., Campeau, R.J. et al. (2007) Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J28: 2667-2677.
122.
Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H. et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res89: E1-E7.
123.
Verma, S., Buchanan, M.R. and Anderson, T.J. ( 2003) Endothelial function testing as a biomarker of vascular disease. Circulation108: 2054-2059.
124.
Walter, D.H., Cejna, M., az-Sandoval, L., Willis, S., Kirkwood, L., Stratford, P.W. et al. (2004) Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis . Circulation110: 36-45.
125.
Walter, D.H., Rittig, K., Bahlmann, F.H., Kirchmair, R., Silver, M., Murayama, T. et al. (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation105: 3017-3024.
126.
Wang, T., Xu, Z., Jiang, W. and Ma, A. ( 2006) Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol109(1): 74-81.
127.
Weaver, W.D., Reisman, M.A., Griffin, J.J., Buller, C.E., Leimgruber, P.P., Henry, T. et al. (2000) Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial. Lancet355: 2199-2203.
128.
Welt, F.G. and Rogers, C. ( 2002) Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol22: 1769-1776.
129.
Werner, N., Junk, S., Laufs, U., Link, A., Walenta, K., Bohm, M. et al. (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res93: e17-e24.
130.
Werner, N., Priller, J., Laufs, U., Endres, M., Bohm, M., Dirnagl, U. et al. (2002) Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase
Widlansky, M.E., Gokce, N., Keaney, Jr J.F. and Vita, J.A. ( 2003) The clinical implications of endothelial dysfunction. J Am Coll Cardiol42: 1149-1160.
Xu, Q., Zhang, Z., Davison, F. and Hu, Y. ( 2003) Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res93: e76-e86.
135.
Yamaguchi, J., Kusano, K.F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S. et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization . Circulation107: 1322-1328.
136.
Yoder, M.C., Mead, L.E., Prater, D., Krier, T.R., Mroueh, K.N., Li, F. et al. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood109: 1801-1809.
137.
Zernecke, A., Schober, A., Bot, I., von Hundelshausen, P., Liehn, E.A., Mopps, B. et al. (2005) SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res96: 784-791.
